Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Abivax (AAVXF) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for Abivax (AAVXF) over the last 4 years, with Q3 2025 value amounting to $38.3 million.

  • Abivax's Non-Current Assets changed N/A to $38.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.3 million, marking a year-over-year change of. This contributed to the annual value of $36.9 million for FY2024, which is 1691.71% down from last year.
  • Latest data reveals that Abivax reported Non-Current Assets of $38.3 million as of Q3 2025.
  • In the past 5 years, Abivax's Non-Current Assets ranged from a high of $44.7 million in Q2 2024 and a low of $36.1 million during Q1 2025
  • Moreover, its 4-year median value for Non-Current Assets was $38.3 million (2025), whereas its average is $39.8 million.
  • In the last 5 years, Abivax's Non-Current Assets soared by 1008.56% in 2023 and then tumbled by 1647.09% in 2024.
  • Quarter analysis of 4 years shows Abivax's Non-Current Assets stood at $40.2 million in 2022, then increased by 10.09% to $44.2 million in 2023, then dropped by 16.47% to $36.9 million in 2024, then grew by 3.7% to $38.3 million in 2025.
  • Its Non-Current Assets was $38.3 million in Q3 2025, compared to $38.0 million in Q2 2025 and $36.1 million in Q1 2025.